Amgen (AMGN) director Garland receives 665 RSUs that vest immediately

Rhea-AI Filing Summary

Garland Greg C. reported acquisition or exercise transactions in this Form 4 filing.

AMGEN INC director Greg C. Garland received 665 shares of common stock through a stock award. The award was a grant of Restricted Stock Units under Amgen’s director incentive program, which vested immediately and was settled in shares on a one-to-one basis. Following this grant, Garland directly holds 13,848 shares of Amgen common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Garland Greg C.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	665	$0.00	--

Holdings After Transaction: Common Stock — 13,848 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 665 shares Grant price per share: $0.00 per share Shares held after grant: 13,848 shares

3 metrics

RSU grant size 665 shares Restricted Stock Units granted to director on transaction date

Grant price per share $0.00 per share Equity award, no cash paid by director

Shares held after grant 13,848 shares Director’s direct Amgen common stock holdings after transaction

Key Terms

Restricted Stock Units (RSUs), Director Incentive Program, Equity Incentive Plan

3 terms

Restricted Stock Units (RSUs) financial

"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

Director Incentive Program financial

"were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended"

Equity Incentive Plan financial

"under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Garland Greg C.

(Last) (First) (Middle)

ONE AMGEN CENTER DRIVE

(Street)

THOUSAND OAKS CALIFORNIA 91320-1799

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		A		665	A	$0	13,848(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.

	/s/ Greg C. Garland	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Amgen (AMGN) director Greg C. Garland report in this Form 4?

Greg C. Garland reported receiving a grant of 665 shares of Amgen common stock via Restricted Stock Units. These RSUs vested immediately and were paid in shares on a one-to-one basis, increasing his direct holdings to 13,848 shares after the transaction.

How many Amgen (AMGN) shares did Greg C. Garland acquire in this transaction?

Greg C. Garland acquired 665 shares of Amgen common stock in this transaction. The shares came from a grant of Restricted Stock Units that vested immediately, rather than from an open-market purchase, and were settled in stock at no cash cost per share.

Was Greg C. Garland’s Amgen (AMGN) stock grant an open-market purchase?

No, the transaction was not an open-market purchase. It was a grant of 665 Restricted Stock Units under Amgen’s director incentive program, which vested immediately and was paid in shares, reflecting equity compensation rather than a discretionary stock buy.

What is Greg C. Garland’s Amgen (AMGN) shareholding after this Form 4 grant?

After the grant, Greg C. Garland directly owns 13,848 shares of Amgen common stock. This total includes the 665 shares received from immediately vesting Restricted Stock Units reported in the Form 4, representing his direct ownership position as of the transaction date.

How are the Restricted Stock Units (RSUs) in this Amgen (AMGN) filing structured?

The RSUs were granted under Amgen’s 2009 Director Incentive Program and vested immediately. Each vested RSU is paid in one share of common stock, and directors may defer payment according to an elected deferral schedule, providing flexibility in timing of share delivery.